BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8584549)

  • 1. Homocysteine: an independent risk factor associated with coronary disease and other arterial occlusive diseases in adults.
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(4):37-8. PubMed ID: 8584549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 3. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma folate adequacy as determined by homocysteine level.
    Lewis CA; Pancharuniti N; Sauberlich HE
    Ann N Y Acad Sci; 1992 Sep; 669():360-2. PubMed ID: 1444047
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid.
    Kruger WD; Evans AA; Wang L; Malinow MR; Duell PB; Anderson PH; Block PC; Hess DL; Graf EE; Upson B
    Mol Genet Metab; 2000 May; 70(1):53-60. PubMed ID: 10833331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperhomocysteinemia is frequent in coronary disease patients. Study of 202 patients].
    Fernández-Miranda C; Aranda JL; Gómez González P; Díaz-Rubio P; Estenoz J; Gómez de la Cámara A
    Med Clin (Barc); 1999 Oct; 113(11):407-10. PubMed ID: 10562951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative view of homocysteine.
    Dudman NP
    Lancet; 1999 Dec; 354(9195):2072-4. PubMed ID: 10636386
    [No Abstract]   [Full Text] [Related]  

  • 8. Homocysteine and coronary artery disease.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 Jan; 6(1):72-7. PubMed ID: 9116791
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].
    Blacher J; Montalescot G; Ankri A; Chadefaux-Vekemans B; Benzidia R; Grosgogeat Y; Kamoun P; Thomas D
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1241-6. PubMed ID: 8952820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
    Blankenberg S; Rupprecht HJ; Peetz D; Bickel C; Hofman KP; Tiret L; Meyer J
    Dtsch Med Wochenschr; 2002 Apr; 127(14):729-35. PubMed ID: 11935469
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    Farhadi D
    N Engl J Med; 1997 Nov; 337(22):1632; author reply 1632-3. PubMed ID: 9411227
    [No Abstract]   [Full Text] [Related]  

  • 12. [Homocysteine as a coronary risk factor].
    Derbeneva SA; Pogozheva AV
    Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betaine in wine: answer to the French paradox?
    Mar MH; Zeisel SH
    Med Hypotheses; 1999 Nov; 53(5):383-5. PubMed ID: 10616037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects.
    Stanger O; Semmelrock HJ; Wonisch W; Bös U; Pabst E; Wascher TC
    J Pharmacol Exp Ther; 2002 Oct; 303(1):158-62. PubMed ID: 12235246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum folate is associated with coronary heart disease independently of homocysteine in Turkish men.
    Onat A; Hergenç G; Küçükdurmaz Z; Can G; Ayhan E; Bulur S
    Clin Nutr; 2008 Oct; 27(5):732-9. PubMed ID: 18694616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine, vitamin B12 and folic acid levels in psoriasis patients.
    Cakmak SK; Gül U; Kiliç C; Gönül M; Soylu S; Kiliç A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):300-3. PubMed ID: 19207655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis.
    Malerba M; Gisondi P; Radaeli A; Sala R; Calzavara Pinton PG; Girolomoni G
    Br J Dermatol; 2006 Dec; 155(6):1165-9. PubMed ID: 17107384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
    Araújo F; Lopes M; Gonçalves L; Maciel MJ; Cunha-Ribeiro LM
    Thromb Haemost; 2000 Mar; 83(3):517-8. PubMed ID: 10744169
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    von Eckardstein A; Assmann G
    N Engl J Med; 1997 Nov; 337(22):1632-3. PubMed ID: 9411228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.